fluorecare® combination test for SARS-CoV-2, influenza A/B and RSV antigen

In the ever-evolving infectious disease landscape, rapid and accurate diagnostic tools are critical to containing disease outbreaks and ensuring public health. The fluorecare® SARS-CoV-2, Influenza A/B & RSV Antigen Combo Test (Pack of 1) offers an innovative and efficient solution for the detection of these common respiratory viruses in a single test. In this blog post, we will discuss the many advantages of the fluorecare® Antigen Combo Test antigen combination test, provide guidance on how to use and handle the test and discuss the target groups for this important diagnostic tool.

Advantages of the fluorecare® SARS-CoV-2, Influenza A/B & RSV Antigen Combination Test

1. The fluorecare® antigen combination testt provides results in just 15 minutes, enabling faster diagnosis and the immediate initiation of appropriate isolation and treatment measures.
2. The test offers high sensitivity and specificity and ensures accurate detection of SARS-CoV-2, Influenza A/B and Respiratory Syncytial Virus (RSV) antigens. This accuracy contributes to more effective disease control and prevention.
3. The fluorecare® antigen combination test was developed to detect all three viruses (SARS-CoV-2, Influenza A/B and RSV) in a single test, saving time and resources while providing comprehensive diagnostic information.
4. The test requires minimal training and can be performed by healthcare professionals in a variety of settings, including clinics, hospitals and point-of-care locations.
5. The fluorecare® Antigen Combination Test offers an affordable solution for rapid virus detection, making it a viable option for large-scale testing campaigns during outbreaks or times of high demand.

Application and operation of the fluorecare® SARS-CoV-2, Influenza A/B & RSV Antigen Combination Test

1. Open the sealed pouch and remove the test cassette, the extraction buffer vial and the sterile swab. Place the test cassette on a clean, flat surface.
2. Use the sterile swab to collect a nasopharyngeal or nasal specimen from the patient, following the specimen collection guidelines.
3. Insert the swab into the extraction buffer vial and rotate it against the inner wall of the vial for at least 10 seconds to release the viral antigens. Press the swab against the inner wall of the vial to extract as much liquid as possible and then discard the swab.
4. Add four drops (approx. 100 μl) of the extracted sample to the sample well of the test cassette.
5. Read the test results after 15 minutes. The appearance of a red line next to the control line (C) indicates that the test is valid. If lines appear next to the markers for SARS-CoV-2 (T1), Influenza A/B (T2) and/or RSV (T3), the test is positive for the corresponding virus(es). If no lines appear next to the virus markers, the test is negative.
6. Dispose of the used test kit and materials according to local regulations for bio-waste.

For whom is the fluorecare® SARS-CoV-2, Influenza A/B & RSV Antigen Combo Test suitable for?

The fluorecare® antigen combination test has been developed for a wide range of users, including

• The test is suitable for healthcare professionals such as doctors, nurses and healthcare professionals who require a rapid and accurate diagnostic tool for the detection of SARS-CoV-2, Influenza A/B and RSV in patients with respiratory symptoms.
• The fluorecare® Antigen Combination Test can be used by public health officials to monitor and control the spread of infectious respiratory diseases in communities, especially during outbreaks or times of high demand.
• The test can be used by businesses, schools and other organizations to screen employees and students for the presence of these viruses to help maintain a safe and healthy environment.
• The fluorecare® Antigen Combination Test can be used by airports, cruise lines and other tour operators to test passengers for the presence of these respiratory viruses to reduce the risk of transmission during travel.
• The test can be used by diagnostic laboratories as a quick and cost-effective alternative to more time-consuming and expensive testing methods such as PCR or virus cultures.

In summary, it can be said that the fluorecare® SARS-CoV-2, Influenza A/B & RSV Antigen Combo Test is a comprehensive, rapid and accurate solution for the detection of these common respiratory viruses. Its user-friendly design and affordable price make it an indispensable tool for healthcare professionals, public health officials and various organizations in their efforts to control and prevent the spread of contagious respiratory diseases. By simultaneously detecting SARS-CoV-2, influenza A/B and RSV, this innovative test contributes to more efficient and effective disease management and public health strategies.

Source: istockphoto PeopleImages